Integra LifeSciences (IART): Company Cash Volume

Official company branding of Integra (IART)

Integra LifeSciences is reforming its manufacturing standards following FDA inspections, which is clearly demonstrated by its current cash position. The value of 0.31 captures the liquidity metric level during this period. Integra LifeSciences is implementing advanced bioengineering solutions for tissue regeneration, leveraging stable hospital demand and the regular updating of its neurosurgery implant portfolio.

Company Cash Funds: Integra LifeSciences Inc. (IART) for 07/04/2022 - 11/21/2026

Summary analytical data breakdowns for Integra LifeSciences Corp (IART)

- stock quotes and analyst forecast:
- stock exchange capitalization data:
- cash balance and cash flow data:
Initial company analysis:Integra LifeSciences Inc. IART
Brand item of Integra LifeSciences Holdings Corporation

The margin of safety for Integra LifeSciences (IART) is determined by the volume of liquid assets, which ensure operational resilience and the ability to generate interest income. By analyzing cash dynamics, an investor assesses the company's capacity to fund production restarts and M&A deals within the neurosurgery sector, transforming this asset into a tool for strategic business scaling.

Analysis of competing companies

Company Cash Volume BSX|Company Cash Funds EW (Edwards Lifesciences Corporation)|Company Cash Funds ResMed RMD|Company Cash Volume Insulet Corp PODD|ZBH: Company Cash on Hand|Company Cash Balance COO (CooperVision)|ALGN (Align Technology, Inc.) - Company Cash on Hand|Globus Medical, Inc. - Company Cash Balance|TMDX (TransMedics Group Inc) - Company Cash Volume|Company Cash Reserve Alphatec Holdings ATEC|Company Cash Funds CryoLife (AORT)|Enovis Corporation (ENOV) - Company Cash Position|Establishment Labs Inc - Company Cash on Hand|Company Cash Volume Beta Bionics Inc BBNX|IRADIMED Corp - Company Cash Volume|Company Liquid Assets Embecta Corp EMBC|Tandem Diabetes Care, Inc. (TNDM) - Company Cash Funds|Company Total Cash Volume AXGN (Axogen Surgical)|Company Cash Funds si-bone.com|Company Cash on Hand Orthofix Medical Inc. (OFIX)|Company Cash Funds Bioventus Corp (BVS)|KIDS - Company Cash Reserve|Company Cash Funds Treace Medical Concepts TMCI|SRTA: Company Cash and Cash Equivalents|CARL: Company Cash on Hand|rxsight.com - Company Total Cash Amount|CLPT: Company Cash Volume|STXS - Company Liquid Assets|STIM (neurostar.com) - Company Cash Volume|Sight Sciences, Inc (SGHT) - Company Liquid Assets|Company Cash Volume OBIO|Company Liquid Assets Anika Therapeutics Inc.|Company Cash Funds InspireMD, Inc. NSPR|Company Cash Balance ZJYL|VANI - Company Cash Funds|Xtant Medical Holdings, Inc. - Company Total Cash Amount|NeuroOne (NMTC) - Company Cash Funds|Modular Med (MODD) - Company Cash Volume|Company Cash Funds Myomo, Inc|Company Cash on Hand Envoy Medical (COCH)|Company Cash Volume VVOS|NVNO (enVVeno Corp) - Company Cash Balance|Company Cash Volume SINT (Sintx Technologies)|TNON: Company Cash and Cash Equivalents|Lifeward - Company Cash Volume|Company Cash Balance AMIX (Autonomix Medical)|IVF: Company Cash Volume|Company Cash Position Bone Biologics Corporation BBLG|Company Cash on Hand AXNX|BIOLASE, Inc. (BIOL) - Company Liquid Assets|Company Cash Volume DYNT|Company Liquid Assets Paragon 28|Company Cash Volume INVO (INVO Bioscience, Inc.)